Homepage
Discover Cellply
Unravelling immune system function, one cell at a time
LAUNCH OF WORKFLOW 2
Cellply Introduces Revolutionary High-Throughput Potency Analysis Technique
SITC 2024 Houston
Cellply S.r.l. is unveiling its groundbreaking high-throughput parallel analysis technique for immune cell therapy potency determination at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting in Houston, TX, 6-10 November 2024.
Partnership
Discover our strategic partnership with Eurofins Biopharma Product Testing (BPT) Italy
Cell and gene therapy development
The strategic partnership with Eurofins Biopharma Product Testing (BPT) Italy will enable cellular therapy developers to access our unique platform which supports the comprehensive characterisation of cells and cell functions at single-cell resolution.
Our flagship product
Introducing the VivaCyte platform
One of a kind analytical system for discovery and process development of cell therapies
VivaCyte enables the characterization of immune cells at an unprecedented resolution and scale, with a fully automated analysis, from sample preparation to image processing.
- 100+ samples per run
- 1,000+ single cells per sample
- many assays per cell